Serum autolog Universitätsspital Basel 20%

Serum autolog Universitätsspital Basel 20% is a medicine authorised by Swissmedic under authorisation number 68547. The authorisation holder is Universitätsspital Basel. The medicinal product code is Transplant: cell therapy product and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 23 February 2026 and the authorisation is limited until 22 February 2031. The export lists no ATC code for this medicine.

  • Dispensing category B
  • Authorisation number 68547
  • Transplant: cell therapy product
Authorisation data
Authorisation number68547
NameSerum autolog Universitätsspital Basel 20%
Full nameSerum autolog Universitätsspital Basel 20%, Augentropfen
Authorisation holderUniversitätsspital Basel
Medicinal product codeTransplant: cell therapy product
Dispensing categoryB · Prescription only
ATC codenot stated
First authorisation23 February 2026
Authorisation validity22 February 2031
Strengths
No.NameDispensing categoryAuthorisation date
1Serum autolog Universitätsspital Basel 20%, AugentropfenB23 February 2026
2Serum autolog Universitätsspital Basel 50%, AugentropfenB23 February 2026

Scroll the table sideways

Pack sizes
Pack codeQuantityUnitATCIT codeDispensing category
1X x 5ml-11.99.0.B
2X x 10ml-11.99.0.B
3X x 5ml-11.99.0.B
4X x 10ml-11.99.0.B

Scroll the table sideways

Frequently asked questions

Is Serum autolog Universitätsspital Basel 20% authorised in Switzerland?

Yes. Serum autolog Universitätsspital Basel 20% is authorised by Swissmedic under authorisation number 68547, data as of 01 September 2026. The authorisation is limited until 22 February 2031.

Which dispensing category does Serum autolog Universitätsspital Basel 20% have?

Serum autolog Universitätsspital Basel 20% is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.

Who is the authorisation holder of Serum autolog Universitätsspital Basel 20%?

The authorisation holder is Universitätsspital Basel. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.

Sources

Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.

Authorisation in Switzerland?

About 2 minutes. No obligation.

First, a little about your business.

Your answers stay in this page until you send your enquiry.

What would you like to achieve?

Your project

Where can we reach you?

You can go back to review your answers before sending.

* Required fields
Prefer email? info@swissmedicinesdirectory.com